BRPI0719395B8 - tablete revestido de filme - Google Patents

tablete revestido de filme Download PDF

Info

Publication number
BRPI0719395B8
BRPI0719395B8 BRPI0719395A BRPI0719395A BRPI0719395B8 BR PI0719395 B8 BRPI0719395 B8 BR PI0719395B8 BR PI0719395 A BRPI0719395 A BR PI0719395A BR PI0719395 A BRPI0719395 A BR PI0719395A BR PI0719395 B8 BRPI0719395 B8 BR PI0719395B8
Authority
BR
Brazil
Prior art keywords
film
coated tablet
film coated
general formula
compound represented
Prior art date
Application number
BRPI0719395A
Other languages
English (en)
Inventor
Maeda Kazuko
Watanabe Tomoyuki
Original Assignee
Daiichi Sankyo Co Ltd
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd, Ube Industries filed Critical Daiichi Sankyo Co Ltd
Publication of BRPI0719395A2 publication Critical patent/BRPI0719395A2/pt
Publication of BRPI0719395B1 publication Critical patent/BRPI0719395B1/pt
Publication of BRPI0719395B8 publication Critical patent/BRPI0719395B8/pt
Publication of BRPI0719395C1 publication Critical patent/BRPI0719395C1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

tablete revestido de filme é revelada uma composição farmacêutica contendo um composto representado pela fórmula geral (i) abaixo simultaneamente tendo estabilidade de armazenagem melhorada. é especificamente revelada uma preparação revestida de filme tendo excelente estabilidade de armazenagem, que contém um composto representado pela fórmula geral (i) abaixo ou um sal farmacologicamente aceitável do mesmo, simultaneamente tendo uma camada de filme contendo um ou mais agentes base de revestimento de filme selecionados de álcool polivinílico, carboximetilcelulose de sódio e pululana.
BRPI0719395A 2006-12-07 2007-12-06 tablete revestido de filme BRPI0719395C1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006330371 2006-12-07
PCT/JP2007/073547 WO2008069262A1 (ja) 2006-12-07 2007-12-06 安定性が改善されたフィルムコーティング製剤

Publications (4)

Publication Number Publication Date
BRPI0719395A2 BRPI0719395A2 (pt) 2015-03-31
BRPI0719395B1 BRPI0719395B1 (pt) 2020-01-21
BRPI0719395B8 true BRPI0719395B8 (pt) 2020-04-07
BRPI0719395C1 BRPI0719395C1 (pt) 2021-05-25

Family

ID=39492140

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0719395A BRPI0719395C1 (pt) 2006-12-07 2007-12-06 tablete revestido de filme

Country Status (9)

Country Link
US (1) US20090291138A1 (pt)
EP (1) EP2100606A4 (pt)
JP (1) JPWO2008069262A1 (pt)
KR (1) KR101665705B1 (pt)
CN (1) CN101594863B (pt)
BR (1) BRPI0719395C1 (pt)
CA (2) CA2823981C (pt)
TW (1) TWI442947B (pt)
WO (1) WO2008069262A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008072534A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited マンニトール又は乳糖を含有する固形製剤
EP2100607A4 (en) * 2006-12-07 2010-01-06 Daiichi Sankyo Co Ltd COATING COMPOSITION WITH IMPROVED DURABILITY
JP5274261B2 (ja) 2006-12-07 2013-08-28 第一三共株式会社 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物
WO2009098142A1 (en) 2008-02-06 2009-08-13 Helm Ag Prasugrel salts with improved properties
TWI438012B (zh) 2008-12-25 2014-05-21 Toray Industries 固態製劑用之塗覆劑及使用其之固態製劑
EP2398468B1 (en) 2009-02-17 2016-11-30 KRKA, D.D., Novo Mesto Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation
DE102009036646A1 (de) 2009-08-07 2011-02-10 Ratiopharm Gmbh Prasugrel in nicht-kristalliner Form und pharmazeutische Zusammensetzung davon
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤
WO2011052499A1 (ja) * 2009-10-28 2011-05-05 第一三共株式会社 貯蔵安定性が改善された医薬組成物
MX2012004316A (es) * 2009-11-30 2012-05-29 Toray Industries Agente de recubrimiento de pelicula para la preparacion de solidos y preparacion de solidos utilizando el mismo.
EP2360159A1 (de) 2010-02-11 2011-08-24 Ratiopharm GmbH Prasugrel in mikronisierter, kristalliner Form und pharmazeutische Zusammensetzung davon
TR201007926A1 (tr) * 2010-07-19 2012-02-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Prasugrel tablet formülasyonları.
TR201005900A1 (tr) * 2010-07-19 2012-02-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Geliştirilmiş stabiliteye sahip prasugrel granülleri.
TR201006802A1 (tr) * 2010-08-17 2012-03-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Prasugrelin oral yolla dağılan formülasyonları.
EP2409685A3 (en) * 2010-07-19 2012-02-01 Sanovel Ilac Sanayi ve Ticaret A.S. Orally-disintegrating formulations of prasugrel
SI2640719T1 (sl) 2010-11-17 2017-07-31 Gilead Pharmasset Llc Antivirusne spojine
PT2663294E (pt) 2011-01-11 2016-01-25 Capsugel Belgium Nv Novas cápsulas duras contendo pululano
JP6082749B2 (ja) 2011-11-16 2017-02-15 ギリアド ファーマセット エルエルシー 抗ウイルス化合物としての縮合イミダゾリルイミダゾール
CZ2011872A3 (cs) 2011-12-22 2013-07-03 Zentiva, K.S. Farmaceutická formulace prasugrelu hydrobromidu
US8603537B2 (en) 2012-04-02 2013-12-10 Egis Pharmaceuticals Plc Prasugrel containing quickly released stable oral pharmaceutical compositions
EA201690473A1 (ru) * 2013-08-27 2017-03-31 ГАЙЛИД ФАРМАССЕТ ЭлЭлСи Комбинированный состав двух противовирусных соединений
US20150064252A1 (en) * 2013-08-27 2015-03-05 Gilead Pharmasset Llc Solid dispersion formulation of an antiviral compound
CN103845302B (zh) * 2014-03-24 2016-03-30 江苏知原药业有限公司 一种性能优异的托法替尼的片剂
TWI721947B (zh) 2014-06-11 2021-03-21 美商基利法瑪席特有限責任公司 抗病毒化合物的固態形式
AU2018253392B2 (en) 2017-04-14 2023-11-02 Capsugel Belgium Nv Process for making pullulan
CN110678170A (zh) 2017-04-14 2020-01-10 比利时胶囊公司 普鲁兰多糖胶囊
KR102820940B1 (ko) * 2022-08-31 2025-06-16 (주)진코스텍 보관 안정성이 증진된 고체형 입욕제 조성물
KR102860813B1 (ko) * 2022-09-23 2025-09-17 (주)진코스텍 다기능성 고체형 클렌저

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS526346B2 (pt) * 1971-10-30 1977-02-21
US3784390A (en) * 1971-07-23 1974-01-08 Hayashibara Biochem Lab Shaped bodies of pullulan and their use
JPS5942325A (ja) * 1982-09-03 1984-03-08 Dai Ichi Seiyaku Co Ltd コ−テイング用組成物及びコ−テイング製剤
US4833617A (en) * 1987-08-14 1989-05-23 General Electric Company Solid modeling based adaptive feedrate control for NC machining
JPH02205A (ja) * 1987-11-09 1990-01-05 Taisho Pharmaceut Co Ltd 香料含有ソフトカプセル用コーティング剤
US5015480A (en) * 1987-11-25 1991-05-14 Eli Lilly And Company Film coating formulations
US4931286A (en) * 1989-04-19 1990-06-05 Aqualon Company High gloss cellulose tablet coating
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
ZA937382B (en) * 1992-10-06 1994-04-29 Warner Lambert Co Novel composition for peroral therapy of cognitionimpairment and a process therefor
JPH0770506A (ja) * 1993-09-07 1995-03-14 Morishita Roussel Kk フイルムコーティング組成物およびそれを用いた固形製剤
JP3583166B2 (ja) * 1994-06-27 2004-10-27 興和株式会社 損傷皮膚修復用粉末製剤
US5542036A (en) * 1994-07-05 1996-07-30 General Electric Company Implicit modeling of swept volumes and swept surfaces
GB9414045D0 (en) * 1994-07-12 1994-08-31 Berwind Pharma Service Moisture barrier film coating composition, method, and coated form
JP3274573B2 (ja) * 1994-08-25 2002-04-15 興和株式会社 フィルムコーティング組成物およびそれを用いた固形製剤
JPH10310586A (ja) 1996-06-26 1998-11-24 Sankyo Co Ltd ヒドロピリジン類の新規医薬用途
US6044306A (en) * 1997-10-14 2000-03-28 Vadim Shapiro Methods and apparatus for shaping moving geometric shapes
US6099573A (en) * 1998-04-17 2000-08-08 Sandia Corporation Method and apparatus for modeling interactions
GB9901887D0 (en) * 1999-01-29 1999-03-17 Lightwork Design Ltd Machining simulation method and apparatus
US6993461B1 (en) * 1999-06-10 2006-01-31 Dassault Systemes Swept volume model
US6740339B1 (en) * 1999-06-18 2004-05-25 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
US6396492B1 (en) * 1999-08-06 2002-05-28 Mitsubishi Electric Research Laboratories, Inc Detail-directed hierarchical distance fields
DE60110666T2 (de) * 2000-03-17 2006-02-02 Shin-Etsu Chemical Co., Ltd. Feste Zubereitung enthaltend niedersubstituierte Hydroxypropylcellulose und Herstellungsverfahren
ATE398624T1 (de) * 2000-07-06 2008-07-15 Daiichi Sankyo Co Ltd Säure-additionssalze von hydropyridinderivaten
JP4001199B2 (ja) * 2000-07-06 2007-10-31 第一三共株式会社 ヒドロピリジン誘導体酸付加塩
EP1175899B1 (fr) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granules à base d'amidon et de lactose
NZ526540A (en) * 2000-12-25 2004-11-26 Sankyo Co Medicinal compositions containing aspirin and 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-flurobenzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine useful in preventing thrombus or embolus diseases
JP4874482B2 (ja) * 2000-12-25 2012-02-15 第一三共株式会社 アスピリンを含有する医薬組成物
US6724393B2 (en) * 2001-03-16 2004-04-20 Mitsubishi Electric Research Labs, Inc. System and method for sculpting digital models
KR100908418B1 (ko) * 2001-06-20 2009-07-21 액티버스 파마 컴퍼니 리미티드 퀴놀리논 유도체 의약 조성물 및 그의 제조 방법
JP4625204B2 (ja) * 2001-07-02 2011-02-02 ウチヤ・サーモスタット株式会社 安全装置付き電源コード
DE10144932B4 (de) * 2001-09-12 2014-07-31 Siemens Aktiengesellschaft Visualisierung von Werkstücken bei der Simulation von Fräsprozessen
JP4029974B2 (ja) 2001-12-21 2008-01-09 第一三共株式会社 ヒドロピリジン誘導体酸付加塩を含有する医薬
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
AU2003248077A1 (en) * 2002-07-18 2004-02-09 Sankyo Company, Limited Medicinal composition for treating arteriosclerosis
JP2004051639A (ja) 2002-07-18 2004-02-19 Sankyo Co Ltd 動脈硬化症治療のための医薬組成物
SI21402A (sl) * 2003-02-12 2004-08-31 LEK farmacevtska dru�ba d.d. Obloženi delci in farmacevtske oblike
US6902609B2 (en) * 2003-02-20 2005-06-07 Bpsi Holdings, Inc. Pearlescent film coating systems and substrates coated therewith
US7042458B2 (en) * 2003-03-25 2006-05-09 Mitsubishi Electric Research Laboratories, Inc. Methods for generating an adaptively sampled distance field of an object with specialized cells
WO2004091600A1 (ja) * 2003-04-16 2004-10-28 Kyorin Pharmaceutical Co., Ltd. 経口固形製剤
JP2006525328A (ja) * 2003-05-05 2006-11-09 イーライ リリー アンド カンパニー 心疾患の治療方法
KR100882156B1 (ko) * 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제
JP5248733B2 (ja) * 2003-11-28 2013-07-31 エスエス製薬株式会社 揮散防止型固形製剤およびその製造方法
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
TWI367755B (en) * 2005-05-20 2012-07-11 Sankyo Co Film coated product
TWI318571B (en) * 2005-06-10 2009-12-21 Lilly Co Eli Formulation of a thienopyridine platelet aggregation inhibitor
EP2100607A4 (en) * 2006-12-07 2010-01-06 Daiichi Sankyo Co Ltd COATING COMPOSITION WITH IMPROVED DURABILITY
WO2008072534A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited マンニトール又は乳糖を含有する固形製剤
JP5274261B2 (ja) * 2006-12-07 2013-08-28 第一三共株式会社 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物
US20110104277A1 (en) * 2009-10-30 2011-05-05 Ma Decheng Oxygen barrier film coatings for pharmaceutical dosage forms

Also Published As

Publication number Publication date
CA2671975C (en) 2013-10-29
TW200831141A (en) 2008-08-01
EP2100606A1 (en) 2009-09-16
TWI442947B (zh) 2014-07-01
WO2008069262A1 (ja) 2008-06-12
KR20090090323A (ko) 2009-08-25
BRPI0719395C1 (pt) 2021-05-25
US20090291138A1 (en) 2009-11-26
BRPI0719395B1 (pt) 2020-01-21
CA2823981A1 (en) 2008-06-12
JPWO2008069262A1 (ja) 2010-03-25
EP2100606A4 (en) 2009-12-30
CN101594863A (zh) 2009-12-02
BRPI0719395A2 (pt) 2015-03-31
CA2823981C (en) 2016-05-17
CN101594863B (zh) 2011-12-07
CA2671975A1 (en) 2008-06-12
KR101665705B1 (ko) 2016-10-12

Similar Documents

Publication Publication Date Title
BRPI0719395B8 (pt) tablete revestido de filme
BRPI0719393B8 (pt) composição farmacêutica
EP4403221A3 (en) Modulators of pharmacokinetic properties of therapeutics
HRP20090077A2 (hr) Modulatori farmakokinetičkih svojstava terapeutika
TW200744588A (en) Pharmaceutical composition for external use
BR112012024019A2 (pt) forma de dosagem de liberação controlada, e, método para liberar uma droga
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
EP2620145A3 (en) 2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ
MX2008012017A (es) Pirazoles como inhibidores de 11-beta-hsd1.
MX2010004435A (es) Compuestos espiro y uso farmaceutico de los mismos.
UA105671C2 (uk) Фармацевтична композиція, яка містить похідне хіноліну
PL2054411T3 (pl) Nowe związki, ich izomery lub ich farmaceutycznie dopuszczalne sole jako antagoniści receptora waniloidowego oraz zawierające je kompozycje farmaceutyczne
UA94606C2 (ru) Производные тиоксантина, композиция, которая их содержит, и их применение в терапии
MX2009011579A (es) Pirimidinonas como moduladores de caseina cinasa ii (ck2).
EA201071204A1 (ru) Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности
TW200806282A (en) Solid dosage formulations
EP1714961A4 (en) INDAZOL COMPOUND AND THEIR PHARMACEUTICAL USE
ES2720869T3 (es) Composiciones farmacéuticas de sevelámero
NI201200170A (es) Formulación farmacéutica en forma de comprimidos de dos capas que comprenden inhibidor de hmg - coa reductasa e irbesartan
TW200643013A (en) Pyrazoles
GB0607954D0 (en) Organic compounds
EA200900631A1 (ru) Замещённые пиразолы и триазолы, как ингибиторы кбв (кинезин-белок веретена)
MY163762A (en) Therapeutic agent for chronic renal failure
MA30341B1 (fr) Dérivés de benzimidazole
BRPI0509194A (pt) formulação e método de comprimido revestido

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/01/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2559 DE 21/01/2020 QUANTO AO TITULAR.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/12/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25D Requested change of name of applicant approved

Owner name: DAIICHI SANKYO COMPANY, LIMITED (JP) ; UBE CORPORATION (JP)